To include your compound in the COVID-19 Resource Center, submit it here.

TLN-4601: Phase II discontinued

Thallion discontinued an open-label Phase II trial after a planned interim analysis

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE